Kuehn Law Encourages Investors of Syndax Pharmaceuticals, Inc. to Contact Law Firm

NEW YORK, Jan. 7, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you are a long-term SNDX stockholder please contact Justin Kuehn, Esq. here, by email at [email protected], or call (833) 672-0814. The consu ...